Expression of cripto in human gall bladder lesions

Journal of Pathology

Volumn 180, Issue 2, 1996, Pages 166-168

  Fujii, Kiyomu ^a   Yasui, Wataru ^a   Kuniyasu, Hiroki ^a   Itoh, Masaki ^a   Hanada, Keiji ^a   Kajiyama, Goro ^a   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

adenocarcinoma; cripto; gall bladder; immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADENOMA; ARTICLE; CONTROLLED STUDY; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; EPIDERMAL GROWTH FACTOR; GALLBLADDER; GALLBLADDER NEOPLASMS; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS;

EID: 0029820459     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199610)180:2<166::AID-PATH641>3.0.CO;2-E     Document Type: Article

References (13)

1. Ciccodicola A, Dono R, Obichi S, et al. Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 1989; 8: 1987-1991.
2. Ciardiello F, Kim M, Saeki T, et al Differential expression of epidermal growth factor-related protein in human colorectal tumors. Proc Natl Acad Sci USA 1991; 88: 7792-7796.
3. Kuniyasu H, Yasui W, Akama Y, et al. Expression of cripto in human gastric carcinomas: an association with tumor stage and prognosis. J Exp Clin Cancer Res 1994; 13: 151-157.
4. Tahara E. Molecular biology of gastric cancer. World J Surg 1995; 19: 484-490.
5. Kuniyasu H, Yoshida K, Yokozaki H, et al. Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas. Jpn J Cancer Res 1991; 82: 969-973.
6. Saeki T, Stromberg K, Qi C-F, et al. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res 1992; 52: 3467-3473.
7. Albores-Saavedra J, Henson DE, Sobin LH. Histological typing of tumors of the gallbladder carcinoma and extrahepatic bile ducts. In: WHO International Histological Typing of Tumors. Berlin: Springer-Verlag, 1992.
8. Beahrs OH, Henson DE, Hutter RVP, et al. (eds). Manual for Staging of Cancer. 4th edn. Philadelphia: J. B. Lippincott, 1992.
9. Yasui W, Hata J, Yokozaki H, et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 1988; 48: 211-217.
10. Impraim CC, Saiki RK, Erlich HA, et al. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissue by enzymatic amplification and hybridization with sequence-specific oligonucleotides. Biochem Biophys Res Commun 1987; 143: 710-716.
11. Yoshida K, Tsuda T, Matsumura T, et al. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch B 1989; 57: 285-290.
12. Tsutsumi M, Yasui W, Naito A, et al. Expression of cripto in human pancreatic tumors. Jpn J Cancer Res 1994; 85: 118-121.
13. Freiss H, Yamanaka Y, Büchler M, et al. Cripto, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 1994; 56: 668-674.